Federal Reserve signals potential rate hike - September 23, 2021

The Food and Drug Administration authorized a booster shot after weeks of deliberation for some Pfizer COVID-19 vaccine recipients. People over 65 and those who are at risk of facing serious complications due to frequent virus exposure at their jobs were recommended a booster at least six months after a second injection. The booster aims to curb the pandemic and the dangerous Delta variant. World Health Organization officials reiterated opposition to the widespread rollout of booster shots for the general public. Annual peak Covid seasons are here to stay. The world of work will pay a big price - CNBC Most Americans will get booster shots soon, doctor predicts - TODAY Doctors Encouraging Flu Vaccinations, Warn Of Double-Punch With COVID-19 - KPBS @PrisonPlanet: The CEO of pharmaceutical giant Moderna says that even younger people will have to get vaccine booster shots at least once every three years, meaning that a two-tier society which punishes the unvaccinated could remain in place indefinitely. The Fed’s rate-setting committee indicated they expect to slow the asset purchases used to support the economy, predicting a raise in interest rates next year and sending a clear signal that policymakers are preparing to taper the $120 billion in monthly asset purchases as soon as November. Federal Reserve policymakers predicted an annual inflation rate of 4.2% by year's end, a 3.4% increase over what they were forecasting in June. US Stocks Rise as Fed Signals Possible 2022 Interest-Rate Hike - The Wall Street Journal Fed Officials See ‘Transitory’ Inflation Lasting Quite a While - The Wall Street Journal @johnauthers: This. The most sensible reading of what Powell just said is that the Fed starts tapering at $15billion per meeting, starting in November. That would get the job finished next June - and it's a more aggressive taper than most seem to be expecting. #FOMC United Airlines is the latest company to face criticism as the number of religious exemptions associated with an increase in COVID-19 vaccine ma